• English
  • 日本語
  • 中文 (中国)
ArisGlobal
  • Products
    • LifeSphere Clinical
      • LifeSphere CTMS
      • LifeSphere eTMF
      • LifeSphere EDC
      • LifeSphere eCOA
    • LifeSphere Regulatory
      • LifeSphere RIMS
      • LifeSphere Publishing
      • LifeSphere IDMP
    • LifeSphere Safety
      • LifeSphere MultiVigilance
      • LifeSphere Intake and Triage
      • LifeSphere Reporting and Analytics
      • LifeSphere Signal and Risk Management
      • LifeSphere LitPro
      • LifeSphere Reporter
      • LifeSphere EV Triage
    • LifeSphere Medical Affairs
      • LifeSphere Medical Information
      • LifeSphere Reporter
      • LifeSphere Product Complaints
    • LifeSphere EasyDocs
    • LifeSphere Nava
  • Insights
    • Blog
    • Resource Center
    • Industry Standard Practices
    • Automation in Pharmacovigilance
    • Clinical Trial Management System
    • Regulatory Information Management Platform
  • Support & Services
    • Managed Services
    • Professional Services
    • LifeSphere Trainings
    • Customer Support
  • News & Events
    • BREAKTHROUGH
    • Events
    • Press Releases
  • Our Company
    • About Us
    • Leadership Team
    • Careers
    • Environmental Social and Corporate Governance
      • Corporate Citizenship
  • Request a Demo
  • Contact Us
Select Page

New Regulatory Capabilities Position ArisGlobal for Future Growth, Report Says

by Ethan Roberson | Apr 5, 2021 | Press Release

ArisGlobal Recognized in Gens & Associates “RIM Software Provider Landscape” February 2021, Market Report Miami, FL. April 6th, 2021 – ArisGlobal, the leading provider of software that automates core product development functions for over 300 global life...

Dr. Reddy’s Laboratories Selects LifeSphere® Signal and Risk Management

by Alberto Cantor | Jan 21, 2021 | Press Release

The leading multination pharmaceutical company plans to use ArisGlobal’s platform to deliver the next generation of integrated signal detection and risk management globally. Miami, FL January 21, 2021 – Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE:...

Zelgen Selects Industry’s First Automated, End-to-End Drug Safety System

by Alberto Cantor | Dec 8, 2020 | Press Release

Rapidly growing biopharma selects ArisGlobal’s LifeSphere® MultiVigilance 10, benefits from industry’s first cognitive automation and AI-enabled safety system, a game-changer for patient safety. MIAMI, Dec. 8, 2020 — ArisGlobal, the leading provider...

ArisGlobal Announces New Executive Positions to Drive Continued Growth

by Alberto Cantor | Dec 7, 2020 | Press Release

MIAMI, FL December 7, 2020 – ArisGlobal, the leading provider of software that automates core product development functions for over 300 global life sciences companies, today announced several key executive hires as it continues to accelerate growth across its global...

EVERSANA and ArisGlobal announce strategic partnership to transform drug safety automation and advance integrated compliance models

by Alberto Cantor | Dec 3, 2020 | Press Release

EVERSANA will leverage ArisGlobal’s end-to-end LifeSphere® Safety platform to strengthen next-generation commercialization services CHICAGO – December 3, 2020 – EVERSANA™, the pioneer of next-generation commercial services to the life sciences industry, and...

ArisGlobal Recognized as a Major Contender in Everest Group’s “Clinical Development Platform Vendors” PEAK Matrix® Assessment 2020

by Alberto Cantor | Nov 19, 2020 | Press Release

Innovation, digitally mature products drive company growth, report says   ArisGlobal, the leading provider of software that automates core product development functions for over 300 global life sciences companies, today announced that it has been named as a Major...
« Older Entries

Recent Posts

  • How to Manage BREXIT Changes with LifeSphere RIMS
  • New Regulatory Capabilities Position ArisGlobal for Future Growth, Report Says
  • Delivering on the Promise of Automation in Pharmacovigilance
  • Unified Development
    Platforms

  • Accelerating Vaccine Pharmacovigilance

Recent Comments

    About ArisGlobal®

    ArisGlobal is transforming the way today’s most successful Life Sciences companies develop breakthroughs and bring new products to market. Our end-to-end drug development technology platform, LifeSphere®, integrates our proprietary Nava® cognitive computing engine to automate all core functions of the drug development lifecycle. Designed with deep expertise and a long-term perspective that spans more than 30 years, LifeSphere® is a unified platform that boosts efficiency, ensures compliance, delivers actionable insights, and lowers total cost of ownership through multi-tenant SaaS architecture.

    Headquartered in the United States, ArisGlobal has regional offices in Europe, India, Japan and China. For more updates, follow ArisGlobal on LinkedIn and Twitter.

    Quick Links

    • Home
    • Company Details
    • Blog
    • Press Releases
    • Careers
    • Contact Us
    • Customer Support

    Products

    • Clinical
    • Regulatory
    • Safety
    • Medical Affairs
    • Nava
    • EasyDocs

    Services

    • Professional Services
    • Managed Services
    • LifeSphere Trainings
    • Facebook
    • Twitter
    • Instagram
    • RSS

    Designed by Elegant Themes | Powered by WordPress